147 related articles for article (PubMed ID: 1851703)
1. Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle.
Maurice DH; Crankshaw D; Haslam RJ
Eur J Pharmacol; 1991 Jan; 192(2):235-42. PubMed ID: 1851703
[TBL] [Abstract][Full Text] [Related]
2. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
4. Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aortic smooth muscle.
Maurice DH; Haslam RJ
Eur J Pharmacol; 1990 Dec; 191(3):471-5. PubMed ID: 1964912
[TBL] [Abstract][Full Text] [Related]
5. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
6. The effect of relaxants working through different transduction mechanisms on the tonic contraction produced in rat aorta by 4 beta-phorbol dibutyrate.
Obianime AW; Dale MM
Br J Pharmacol; 1989 Jul; 97(3):647-56. PubMed ID: 2758236
[TBL] [Abstract][Full Text] [Related]
7. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
9. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and cyclic nucleotides participate in the relaxation of diclofenac on rat uterine smooth muscle.
Pérez Vallina JR; Menéndez Antolin L; Cantabrana B; Sánchez M; Hidalgo A
Gen Pharmacol; 1998 Jan; 30(1):25-9. PubMed ID: 9457477
[TBL] [Abstract][Full Text] [Related]
11. Effect of vasoactive intestinal polypeptide (VIP) on cyclic AMP level and relaxation in rat isolated aorta.
Schoeffter P; Stoclet JC
Eur J Pharmacol; 1985 Feb; 109(2):275-9. PubMed ID: 2986998
[TBL] [Abstract][Full Text] [Related]
12. Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels.
Lindgren SH; Andersson TL; Vinge E; Andersson KE
Acta Physiol Scand; 1990 Oct; 140(2):209-19. PubMed ID: 2176433
[TBL] [Abstract][Full Text] [Related]
13. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.
Moncada S; Rees DD; Schulz R; Palmer RM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2166-70. PubMed ID: 1848694
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibitory effects of atriopeptin II and isoproterenol on contraction of rat aortic smooth muscle: roles of cGMP and cAMP.
Jang EK; Davidson MM; Crankshaw D; Haslam RJ
Eur J Pharmacol; 1993 Dec; 250(3):477-81. PubMed ID: 8112409
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
16. Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.
Dembinska-Kiec A; Pallapies D; Simmet T; Peskar BM; Peskar BA
Br J Pharmacol; 1991 Dec; 104(4):811-6. PubMed ID: 1725764
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.
Linde C; Quast U
Br J Pharmacol; 1995 Jun; 115(3):515-21. PubMed ID: 7582466
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
Delpy E; le Monnier de Gouville AC
Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
20. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels.
Carrier GO; Fuchs LC; Winecoff AP; Giulumian AD; White RE
Am J Physiol; 1997 Jul; 273(1 Pt 2):H76-84. PubMed ID: 9249477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
